Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02561728
Other study ID # 2015-1748
Secondary ID
Status Withdrawn
Phase N/A
First received September 25, 2015
Last updated June 27, 2016
Start date July 2016
Est. completion date October 2023

Study information

Verified date June 2016
Source Children's Hospital Medical Center, Cincinnati
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to examine a group of patients requiring helmet therapy (either patients with plagiocephaly or post-surgical patients) to compare outcomes of infants treated with the Hanger helmet (Hanger, Inc.) to outcomes of infants treated with the P Pod Helmet (Lorica Scientific, LLC). Currently both helmets are prescribed at CCHMC. The investigators' goal is to determine which helmet is more effective in skull remodeling and to standardize the investigators' care for these patient types.


Description:

The use of helmet therapy to correct abnormal head shape due to either positional plagiocephaly secondary to pressure on the posterior skull with infant position and furniture use or after minimally invasive surgery for craniosynostosis is currently the treatment of choice at Cincinnati Children's Hospital (CCHMC). Helmet treatment in children with positional plagiocephaly is initiated for infants between 4 and 9 months of age (at CCHMC). Helmet treatment for children undergoing surgery for craniosynostosis is initiated following endoscopic cranial vault and stip craniectomy surgery after swelling from the surgery has subsided (generally within two weeks of surgery). Treatment with helmet therapy has been shown to improve head shape in both patient diagnoses. There are two types of helmets available to the investigators' patients (Hanger Helmet and P Pod Helmet) and to date, no research has evaluated whether one helmet type is more efficient in reshaping the skull than the other type. The current study seeks to fill this gap in the literature by comparing the outcomes for infants treated with a Hanger Helmet to the outcomes for infants treated with a P Pod Helmet. The investigators will measure skull symmetry with a 3dMD camera and take routine cross lateral measurements with a caliper designed for this use. Infants participating in the study will be randomized using a computerized program, Minim.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date October 2023
Est. primary completion date October 2022
Accepts healthy volunteers No
Gender Both
Age group N/A to 10 Months
Eligibility Inclusion Criteria:

- Diagnosis which requires helmet therapy treatment

- Under 10 months of age

Exclusion Criteria:

- Children who do not need helmet therapy

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Hangar Helmet
Child will be fitted with the Hangar Helmet
P-Pod Helmet
Child will be fitted with the P-Pod Helmet

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Children's Hospital Medical Center, Cincinnati

Outcome

Type Measure Description Time frame Safety issue
Primary Root Mean Square (RMS) RMA is measured by first taking a picture of the child's head with the helmet on with a 3dMD camera. RMS is a measurement unique to the 3dMD camera. RMS will be used to quantify symmetry by superimposing left and right quadrants and calculating the mean value of aggregate distances between surfaces. 5 years No
See also
  Status Clinical Trial Phase
Withdrawn NCT00769847 - Endoscopic Treatment for Isolated, Single Suture Craniosynostosis N/A
Completed NCT00077831 - Child and Infant Learning Project N/A
Recruiting NCT03231085 - Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child N/A
Active, not recruiting NCT02229968 - Efficacy of Amicar for Children Having Craniofacial Surgery Phase 2
Completed NCT02287805 - Qualitative and Quantitative Study Which Aims to Determine the Specifics of the Announcement for the Diagnosis of Patients With Craniosynostosis and Their Parents to Better Support Them in Their Care N/A
Enrolling by invitation NCT05911139 - Influence of General Anesthesia on the Dynamic Changes in Brain Damage Markers During and After Craniosynostosis Operations in Infancy
Completed NCT00912119 - Amicar Pharmacokinetics of Children Having Craniofacial Surgery Phase 1
Completed NCT00106977 - Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis)
Terminated NCT00722436 - Tranexamic Acid for Craniofacial Surgery Phase 4
Completed NCT00367796 - Genetic Analysis of Craniosynostosis, Philadelphia Type N/A
Completed NCT01898650 - MRI for Non-invasive Evaluation of Brain Stress N/A
Active, not recruiting NCT03025763 - Network Of Clinical Research Studies On Craniosynostosis, Skull Malformations With Premature Fusion Of Skull Bones
Completed NCT02188576 - The Efficacy and Population Pharmacokinetics of Tranexamic Acid for Craniosynostosis Surgery Phase 4
Completed NCT00773643 - Osteogenic Profiling of Tissue From Children With Craniosynostosis N/A
Enrolling by invitation NCT04704284 - Comparing MRI to CT on Pediatric Craniosynostosis. N/A